S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
NASDAQ:AIKI

AIkido Pharma News Headlines

$0.70
+0.01 (+1.71%)
(As of 12/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.68
$0.71
50-Day Range
$0.67
$0.88
52-Week Range
$0.55
$2.55
Volume
2.19 million shs
Average Volume
7.42 million shs
Market Capitalization
$62.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.42

Media Mentions By Week



AIkido Pharma Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AIKI
News Sentiment

0.89

0.34

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AIKI Articles
This Week

5

1

AIKI Articles
Average Week

Get AIkido Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter.

AIkido Pharma (NASDAQ:AIKI) News Headlines Today

SourceHeadline
marketbeat.com logoPenny Picks: The Top Penny Stocks of 2021 and Beyond (AIKI)
marketbeat.com - October 20 at 10:09 AM
MarketBeat logoAIkido Pharma (NASDAQ:AIKI) Stock Price Up 1.7%
americanbankingnews.com - December 8 at 12:28 AM
finance.yahoo.com logoAIkido Pharma Announces Strategic Interest in ASP Isotopes Inc.
finance.yahoo.com - December 6 at 12:59 PM
nasdaq.com logoCompanies Like AIkido Pharma (NASDAQ:AIKI) Are In A Position To Invest In Growth
nasdaq.com - December 2 at 11:23 PM
finance.yahoo.com logoWe're Hopeful That AIkido Pharma (NASDAQ:AIKI) Will Use Its Cash Wisely
finance.yahoo.com - December 2 at 7:44 AM
MarketBeat logoHead to Head Survey: Absci (NASDAQ:ABSI) and AIkido Pharma (NASDAQ:AIKI)
americanbankingnews.com - December 2 at 1:12 AM
MarketBeat logoAnalyzing AIkido Pharma (AIKI) and Its Peers
americanbankingnews.com - November 29 at 11:14 PM
MarketBeat logoHead to Head Comparison: AIkido Pharma (AIKI) versus The Competition
americanbankingnews.com - November 29 at 11:14 PM
MarketBeat logoReviewing AIkido Pharma (AIKI) & Its Peers
americanbankingnews.com - November 28 at 9:08 PM
MarketBeat logoAnalyzing AIkido Pharma (AIKI) and Its Rivals
americanbankingnews.com - November 28 at 5:08 PM
MarketBeat logoHead-To-Head Contrast: AIkido Pharma (AIKI) & The Competition
americanbankingnews.com - November 27 at 7:10 PM
MarketBeat logoAIkido Pharma (AIKI) & Its Competitors Financial Analysis
americanbankingnews.com - November 27 at 11:08 AM
MarketBeat logoAIkido Pharma (AIKI) and The Competition Critical Comparison
americanbankingnews.com - November 26 at 9:16 PM
MarketBeat logoCritical Review: AIkido Pharma (AIKI) vs. The Competition
americanbankingnews.com - November 26 at 5:14 PM
MarketBeat logoHead to Head Analysis: AIkido Pharma (AIKI) & Its Peers
americanbankingnews.com - November 26 at 11:24 AM
MarketBeat logoAIkido Pharma (AIKI) & Its Competitors Financial Survey
americanbankingnews.com - November 26 at 5:12 AM
MarketBeat logoComparing AIkido Pharma (AIKI) & Its Rivals
americanbankingnews.com - November 26 at 3:16 AM
MarketBeat logoFinancial Contrast: AIkido Pharma (AIKI) vs. The Competition
americanbankingnews.com - November 24 at 5:18 PM
MarketBeat logoCritical Comparison: AIkido Pharma (AIKI) and Its Competitors
americanbankingnews.com - November 22 at 11:20 AM
MarketBeat logoAIkido Pharma Inc. (NASDAQ:AIKI) Expected to Post Earnings of -$0.01 Per Share
americanbankingnews.com - November 19 at 7:12 PM
MarketBeat logoCritical Contrast: AIkido Pharma (AIKI) and Its Rivals
americanbankingnews.com - November 18 at 11:16 PM
MarketBeat logoComparing AIkido Pharma (AIKI) and Its Competitors
americanbankingnews.com - November 18 at 7:10 PM
MarketBeat logoAIkido Pharma (AIKI) & Its Rivals Financial Survey
americanbankingnews.com - November 18 at 1:17 PM
MarketBeat logoAIkido Pharma Inc. (NASDAQ:AIKI) Sees Significant Increase in Short Interest
americanbankingnews.com - November 18 at 5:20 AM
MarketBeat logoAIkido Pharma (AIKI) & Its Competitors Financial Review
americanbankingnews.com - November 17 at 5:16 PM
MarketBeat logoContrasting AIkido Pharma (AIKI) & Its Rivals
americanbankingnews.com - November 17 at 11:09 AM
MarketBeat logoAIkido Pharma (NASDAQ:AIKI) Stock Price Down 2.4%
americanbankingnews.com - November 17 at 12:38 AM
MarketBeat logoAIkido Pharma Inc. (NASDAQ:AIKI) Short Interest Up 281.5% in October
americanbankingnews.com - November 16 at 4:02 AM
MarketBeat logoCritical Survey: AIkido Pharma (AIKI) & Its Competitors
americanbankingnews.com - November 15 at 7:12 PM
MarketBeat logoCritical Contrast: AIkido Pharma (AIKI) versus Its Rivals
americanbankingnews.com - November 14 at 3:06 AM
finance.yahoo.com logoAIkido Pharma Announces Third Quarter Highlights and Corporate Update
finance.yahoo.com - November 11 at 10:18 AM
benzinga.com logoHC Wainwright & Co. Initiates Coverage On AIkido Pharma with Buy Rating, Announces Price Target of $2
benzinga.com - October 11 at 1:03 PM
benzinga.com logoAlkido Pharma Trading 30% Below Cash Value Despite Positive Indications
benzinga.com - October 6 at 11:29 AM
marketwatch.com logoAIkido Pharma Takes Stake in Electric Truck Co., Shares Rise
marketwatch.com - September 30 at 5:43 AM
finance.yahoo.com logoAIkido Pharma Secures Interest in Electric Truck Maker, Tevva Motors Ltd
finance.yahoo.com - September 28 at 12:55 PM
finance.yahoo.com logoAIkido Pharma Secures Interest in Growing Tele-health Company
finance.yahoo.com - September 20 at 9:20 AM
finance.yahoo.com logoNotice of Allowance Issued for Central Nervous System Peptide Technology
finance.yahoo.com - July 27 at 10:54 AM
msn.com logoBRIEF-Aikido Pharma Issues Update On Antiviral Platform With University Of Maryland
msn.com - July 16 at 8:03 PM
finance.yahoo.com logoAIkido Pharma Issues Update on Antiviral Platform with the University of Maryland
finance.yahoo.com - July 16 at 3:02 PM
finance.yahoo.com logoAIkido Pharma to Attend the Alzheimer's Association International Conference
finance.yahoo.com - July 13 at 12:15 PM
finance.yahoo.com logoAIkido Pharma Files Patent Application for the Use of Ketamine to Treat Alzheimer's Disease
finance.yahoo.com - June 23 at 10:04 AM
finance.yahoo.com logoCompanies Like AIkido Pharma (NASDAQ:AIKI) Can Afford To Invest In Growth
finance.yahoo.com - June 5 at 8:45 AM
finance.yahoo.com logoAIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591
finance.yahoo.com - June 4 at 9:41 AM
finance.yahoo.com logoAIkido Pharma Has Pending Data Results on June 4th, with Strongest Balance Sheet in Its History While Trading Below Cash
finance.yahoo.com - May 20 at 6:15 PM
finance.yahoo.com logoAIkido Pharma Announces Phase 1 Data To Be Presented at the American Society of Clinical Oncology ("ASCO") Annual Meeting
finance.yahoo.com - May 20 at 1:15 PM
finance.yahoo.com logoAIKI Featured as Stock to Watch Ahead of Significant Key Milestones
finance.yahoo.com - May 19 at 8:46 AM
finance.yahoo.com logoAIKI's Near Term Catalyst Approaching this Quarter with Strong Cash Balance Sheet for Strategic Initiatives
finance.yahoo.com - May 13 at 9:38 AM
finance.yahoo.com logoAIkido Pharma Inc.: Invitation to the Q2 Virtual Investor Summit
finance.yahoo.com - May 13 at 9:38 AM
finance.yahoo.com logoAIkido Pharma Inc. to Present at the Benzinga Global Small Cap Conference, the Investor Summit Group's Conference, and the LD Micro Invitational Conference
finance.yahoo.com - May 12 at 9:19 AM
finance.yahoo.com logoAIkido Pharma Inc. Announces First Quarter 2021 Results and Provides Corporate Update
finance.yahoo.com - May 11 at 9:42 AM
finance.yahoo.com logoAIkido Pharma Inc. Announces Participation in the Benzinga Global Small Cap Conference
finance.yahoo.com - May 6 at 7:10 AM
Get AIkido Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.